Abstract

Objective To evaluate the risk factors for early rebleeding (ERB) after elective endo- scopic variceal ligation (EVL) in cirrhotic patients and the influence of ERB on the long-term survival. Methods A total of 198 cirrhotic patients who received elective EVL were retrospectively evaluated. Twen- ty-six patients rebleeded within 6 weeks after initial EVL and were assigned to the ERB group. One hundred and seventy-two other cirrhotic patients were assigned to the control group. Multivariate analysis was used to define the high risk factors of ERB. A Kaplan-Meier analysis was performed to evaluate the cumulative sur- vival rates between two groups. Results The Child-Pugh classification ( P = 0. 016 ), Child-Pugh scores (P =0. 012), and the total bilirubin (P = 0. 001 ) were significantly different between ERB and control group. Multivariate analysis showed total bilirubin was the only independent risk factor of ERB ( OR = 2.02, 95%CI: 1.04-4.04, P = 0.008). The proportional mortality indicator of bleeding-related deaths was 66. 7% (10/15) in ERB group and 13.6% (6/44) in control group (P 〈0. 01 ). The five-year cumulative survival rate of the control-group was significantly higher than that of the rebleeding group ( 67. 8% vs. 25.3%, P 〈 0. Ol ). Conclusion Cirrhotic patients with ERB after elective EVL have a poor prognosis. High level of total bilirubin may predict ERB. Key words: Liver cirrhosis; Esophageal varices; Rebleeding; Endoscopic variceal ligation

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.